Nepal is a Himalayan country that has surplus potential in hydropower generation. It lies among the largely populated countries such as India, China, Bangladesh and Pakistan. Nepal can be a country to fulfill its demand. However, for a few decades, Nepal has been suffering from domestic power shortages. This review study holds attention to intrinsic developmental barriers that stem from the domestic power supply, internal governance systems, and indigenous societal sensitivity. The barrier behind the unavailability of Nepal to export electric power is its insufficient production which is dragged by: energy treading policies, technical, environmental, economical, and financial factors, political and regulatory barriers, social and cultural barriers.
Background: The COVID-19 pandemic has challenged the entire globe and the need for a vaccine is supreme. Since many vaccines along with Covishield have been granted emergency use authorization, the evaluation and monitoring of safety are crucial. Covishield was rolled out in Nepal on January 27, 2021. So through this study, we aim to identify the prevalence of Adverse Events Following Immunization in general with the first dose of Covishield vaccine, compare Adverse Events Following Immunization in prior COVID-19 positive cases and Adverse Events Following Immunization in co-morbid individuals. Methods: This was a descriptive cross-sectional study conducted in 440 sample from May 2021 till July 2021 in a provincial government hospital of western Nepal. Ethical approval was received from Ethical Review Board, Nepal Health Research Council (Registration no: 279/2021 P). Simple random sampling was used. Point estimate was done at 95% confidence interval and descriptive analysis was done to identify the prevalence of Adverse Events Following Immunization within one week after Covishield vaccination in the studied population.Results: 79.77% of the study population complaint at least one or more Adverse Events Following Immunization. Fever, myalgia, headache, pain at the injection site, arthralgia, chills, and fever are the most common Adverse Events Following Immunization. 42.73% of the study population self-medicated to manage Adverse Events Following Immunization, 7.89% took leave from work while 0.28% needed medical attention. No major Adverse Events Following Immunization relevance with prior-COVID history or co-morbidity was seen.Conclusions: Majority of the vaccinated participants had minor adverse effects on the first-day post-vaccination while most of the Adverse Events Following Immunization subsided within seven days. Keywords: Adverse effects; COVID-19 vaccines COVISHIELD; pharmacovigilance; side effects.
Empirical research supporting computational models of narrative is often constrained by the lack of large-scale corpora with deep annotation. In this paper, we report on our annotation and analysis of a dataset of 283 individual narrations of the events in two short video clips. The utterances in the narrative transcripts were annotated to align with known events in the source videos, offering a unique opportunity to study the regularities and variations in the way that different people describe the exact same set of events. We identified the causal relationships between events in the two video clips, and investigated the role that causality plays in determining whether subjects will mention a particular story event and the likelihood that these events will be told in the order that they occurred in the original videos.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.